Lexiva en es it fr

Lexiva Brand names, Lexiva Analogs

Lexiva Brand Names Mixture

  • No information avaliable

Lexiva Chemical_Formula


Lexiva RX_link


Lexiva fda sheet

Lexiva FDA

Lexiva msds (material safety sheet)

Lexiva Synthesis Reference

No information avaliable

Lexiva Molecular Weight

505.628 g/mol

Lexiva Melting Point

No information avaliable

Lexiva H2O Solubility

No information avaliable

Lexiva State


Lexiva LogP


Lexiva Dosage Forms


Lexiva Indication

For the treatment of HIV-1 infection in combination with other antiretroviral agents.

Lexiva Pharmacology

Amprenavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease. HIV-1 protease is an enzyme required for the proteolytic cleavage of the viral polyprotein precursors into the individual functional proteins found in infectious HIV-1. Amprenavir binds to the protease active site and inhibits the activity of the enzyme. This inhibition prevents cleavage of the viral polyproteins resulting in the formation of immature non-infectious viral particles. Protease inhibitors are almost always used in combination with at least two other anti-HIV drugs.

Lexiva Absorption

No information avaliable

Lexiva side effects and Toxicity

No information avaliable

Lexiva Patient Information

Lexiva Organisms Affected

Human immunodeficiency virus